Do weight loss injections give you energy — or take it away?

Fatigue and mild tiredness are recognised early side effects of GLP-1 and dual-agonist medicines, most often during the first one to four weeks or after a dose increase.
Weight reduction itself tends to reduce strain on the heart, joints and sleep quality — changes that many people describe as feeling more energetic over time.
Dehydration from early nausea or reduced appetite can worsen tiredness; steady fluid intake is one of the most practical things you can do to manage it.
Persistent or worsening fatigue (especially alongside stomach pain, dizziness or shortness of breath) should be reviewed by a prescriber or GP promptly.

Weight loss injections such as Mounjaro (tirzepatide) and Wegovy (semaglutide) are not licensed to treat fatigue or boost energy directly, yet many people on these medicines do report feeling more energetic over time. The honest answer is: it depends on where you are in treatment. In the first few weeks, tiredness is common. As weight reduces and metabolic health improves, many people find their energy levels lift noticeably. These are prescription-only weight loss injections requiring clinical assessment; whether they are suitable for you is a decision made with a prescriber, not a product you can self-select.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How energy levels tend to shift across the different stages of treatment

Stage 1, the adjustment period (weeks one to four): why tiredness is normal

Starting a GLP-1 medicine or its dual-agonist equivalent is a real physiological shift. Gastric emptying slows, appetite drops, and your body is taking in fewer calories than it was used to. That adjustment frequently shows up as fatigue. The NHS patient information for tirzepatide lists tiredness among the common early side effects, alongside nausea and digestive changes.

It helps to understand the sequencing. The starter dose (2.5 mg for tirzepatide, 0.25 mg for semaglutide) exists primarily so your system acclimatises gradually; it is not the dose that drives significant weight change. That means the tiredness some people feel early on arrives before most of the weight-loss benefit does. Knowing this makes the first few weeks easier to sit with.

The practical checking habit worth building: before bed each night in the first fortnight, glance at how much water you have drunk. Mild dehydration from reduced appetite or a bout of nausea amplifies tiredness considerably, and it takes under a minute to notice whether your intake has slipped. Most adults on these medicines benefit from consciously keeping fluids up, especially on days when food feels unappealing.

Stage 2, settling in: when energy often begins to recover

For most people, the early fatigue lifts within two to four weeks. As the body adjusts to its new intake and the gastrointestinal side effects settle, reported energy levels tend to stabilise and then, gradually, improve. This is not a placebo effect. Carrying less body weight reduces the mechanical load on joints, lowers resting heart rate in many people, and (if excess weight was disrupting sleep) often improves sleep quality meaningfully.

Sleep apnoea, for example, is more common among people with obesity, and the NHS England guidance on weight management injections lists obstructive sleep apnoea as one of the weight-related conditions that can qualify someone for treatment. As weight reduces, sleep apnoea frequently improves, and better sleep is one of the most direct routes to feeling more awake during the day.

Blood pressure and cholesterol often improve alongside weight loss too. None of these changes happen overnight, but by months two or three, the picture is usually clearer. If you are weighing up which medicine to start with, our page on the novo weight loss injection explains how semaglutide works and what to expect from it. You can read more about the broader process on the weight loss treatment overview.

Stage 3, sustained treatment: reading the signals correctly

Once settled on a maintenance dose, most people do not think of fatigue as a dominant feature of their experience. That said, tiredness at this stage warrants attention rather than assumption. Possible causes range from the harmless (a disrupted night, a busy week) to the medically relevant.

A few signs that should prompt a conversation with a prescriber rather than waiting: fatigue accompanied by severe or persistent stomach pain (pancreatitis is an infrequent but serious side effect of GLP-1 medicines, the MHRA highlighted this in its January 2026 Drug Safety Update), dizziness, a significant drop in urine output, or low mood. None of these are common, but they are the signals that distinguish ordinary tiredness from something worth investigating.

It is also worth checking whether calorie intake has fallen too sharply. Medicines like Mounjaro are very effective appetite suppressants, and some people under-eat to the point where protein and micronutrient intake suffers. A prescriber or dietitian can help calibrate this; our frequently asked questions cover some of the nutrition questions that come up most often.

If you are in the process of exploring whether a GP can give weight loss injections and what that pathway involves, or you want to understand the full range of treatment options and how assessment works, both pages lay out the process clearly. For those already injecting and wondering about technique, the guide to self-injection covers practical steps that reduce discomfort and site reactions, which in turn support consistency.

On the question of cost, our weight loss injections price page explains what a legitimate private prescription includes and why clinical oversight is part of the price, not an optional extra. If you are also thinking about donating blood while on treatment, our page on whether you can give blood on weight loss injections sets out the current guidance and what to discuss with your donation centre.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions